Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.4800

0.0000

(0.00%)

At close: 04:00PM EDT

1.4500

-0.03

(-2.03%)

After hours:

07:55PM EDT

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	18.49M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
SCHUETZ THOMAS J Officer and Director	Stock Award(Grant) at price 1.93 per share.	Direct	1,230,375	09 Jan 2024	637,500
BISKER-LEIB VERED Chief Executive Officer	Stock Award(Grant) at price 1.93 per share.	Direct	3,383,531	09 Jan 2024	1,753,125
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.37 per share.	Direct	33,700	10 Mar 2023	10,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.98 per share.	Direct	79,600	27 Feb 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.86 per share.	Direct	77,200	15 Feb 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	08 Feb 2023	500,000
BISKER-LEIB VERED Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	08 Feb 2023	400,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 4.05 per share.	Direct	81,000	31 Jan 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 4.19 per share.	Direct	83,800	24 Jan 2023	20,000
BISKER-LEIB VERED Chief Operating Officer	Sale at price 4.19 - 4.36 per share.	Direct	103,708	25 Nov 2022	24,500
BISKER-LEIB VERED Chief Operating Officer	Sale at price 4.34 - 4.40 per share.	Direct	96,986	21 Nov 2022	22,261
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.25 per share.	Indirect	1,708,500	08 Nov 2022	402,000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.25 per share.	Indirect	1,708,500	08 Nov 2022	402,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.32 per share.	Direct	23,200	28 Sept 2022	10,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.27 per share.	Direct	34,050	26 Sept 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.03 per share.	Direct	45,450	07 Sept 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.83 per share.	Direct	42,450	01 Sept 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.05 per share.	Direct	45,750	17 Aug 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.64 per share.	Direct	39,600	10 Aug 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.58 per share.	Direct	38,700	01 Aug 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.80 per share.	Direct	56,000	21 Jun 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.34 per share.	Direct	46,800	16 Jun 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.29 per share.	Direct	68,700	13 Jun 2022	30,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.83 per share.	Direct	84,900	06 Jun 2022	30,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.03 per share.	Direct	60,600	01 Jun 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.04 per share.	Direct	60,800	26 May 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.72 per share.	Direct	49,926	23 May 2022	18,355
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.47 per share.	Direct	49,931	17 May 2022	20,215
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.79 - 2.49 per share.	Indirect	420,482	13 May 2022	192,516
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.79 - 2.49 per share.	Indirect	420,482	13 May 2022	192,516
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.56 - 1.63 per share.	Indirect	197,252	10 May 2022	125,359
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.56 - 1.63 per share.	Indirect	197,252	10 May 2022	125,359
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 1.80 per share.	Direct	50,105	10 May 2022	27,836
SCHUETZ THOMAS J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Nov 2021	600,000
BISKER-LEIB VERED Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Nov 2021	600,000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.50 per share.	Indirect	18,750,000	04 Nov 2021	5,357,143
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.50 per share.	Indirect	18,750,000	04 Nov 2021	5,357,143

NIKKEI 22537,657.97+29.49(+0.08%)

HANG SENG17,284.54+83.27(+0.48%)

CRUDE OIL83.87+0.30(+0.36%)

GOLD FUTURES2,341.10-1.40(-0.06%)

DOW38,085.80-375.12(-0.98%)

Bitcoin GBP51,421.06-199.35(-0.39%)

Trending tickers

Compass Therapeutics, Inc. (CMPX)

Insider transactions

Insider transactions reported - last two years

NIKKEI 225
37,657.97
+29.49(+0.08%)

HANG SENG
17,284.54
+83.27(+0.48%)

CRUDE OIL
83.87
+0.30(+0.36%)

GOLD FUTURES
2,341.10
-1.40(-0.06%)

DOW
38,085.80
-375.12(-0.98%)

Bitcoin GBP
51,421.06
-199.35(-0.39%)